Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in highly active antiretroviral therapy to treat HIV-1 infection by blocking viral replication. This category provides a comprehensive… Read more





























![Chemical structure of rac 5-Chloro-a-(cyclopropylethynyl)-2-[[(4-methoxyphenyl)methyl]amino] -a-(trifluoromethyl)benzenemethanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F221177-56-6-rac-5-Chloro-a-cyclopropylethynyl-2-4-methoxyphenylmethylamino-a-trifluoromethylbenzenemethanol.png&w=3840&q=75)








![Chemical structure of rac N-[4-Chloro-2-[3-cyclopropyl-1-hydroxy-1-(trifluoromethyl)-2-propynyl]phenyl]-4-methoxybenzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1189491-03-9-rac-N-4-Chloro-2-3-cyclopropyl-1-hydroxy-1-trifluoromethyl-2-propynylphenyl-4-methoxybenzamide.png&w=3840&q=75)


Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in highly active antiretroviral therapy to treat HIV-1 infection by blocking viral replication. This category provides a comprehensive selection of Efavirenz reference standards, including pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, degradation products, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for essential analytical procedures, such as method validation, stability testing, and rigorous impurity profiling. By incorporating these structurally characterized compounds into workflows, researchers can effectively perform forced degradation studies and genotoxicity screening in alignment with global quality control standards. These labelled and unlabelled standards are vital for the identification and quantification of impurities in drug substances, ensuring consistent therapeutic efficacy and safety during the manufacturing and regulatory compliance process.